Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks Sam. Inflated numbers due to holiday rebound, but still nice to see.
Thanks Sam. We'll see a big post holiday bounce and likely ATH next week.
Amazing that you got a prompt response. Nice news. Thanks
Thanks Sam. And lets get some good premarket news Monday.
Thanks SAM. Could you just post non-normalized raw numbers for new and refills? Don't need history, L numbers, analysis or market share. I've been tracking since launch and would like to keep it up for consistency. Thanks if you can.
Nonnormalized numbers show consistent growth numbers since launch. The normalized numbers are a new stat and don't allow for YOY or any seasonality comparisons. They may be less valid but are more reliable. I'd rather keep the same measuring stick. That said, ATH is ATH, but just less valuable to me.
Sam, can you publish non-normalized numbers as well. Realize that it's more work, but we can pay you double. Thanks!
Future's so bright, gotta wear shades...Now if we can just avoid getting f**cked at the ADCOM...
Thanks Sam. Appreciate the "old" numbers. To simplify, can you just post the raw New and Refill numbers the old way. i can add total and have history.
Can you post numbers not normalized? Thanks Sam
Thanks Sam. Can you post the NONnormaliized scripts? These are instructive as they are comparable since the product launch. Thanks in advance.
I track the 4 week average from Sam's numbers. These show very steady upward climb and filter out some of the noise of week to week numbers. Also provides for a lot more sanity tracking Amarin.
Miami Conference feedback? Anyone hear new from the weekend's conference in Miami?
Thanks Sam. Awesome numbers. Last week was a bounce back. This is 45K for real. Very exciting slope.
Hockey stick grows! thanks Sam for the numbers. Very good numbers indeed. Might see 50K totals by the end of July.
Thanks Sam. Guess we don't get an ATH every week, huh? That's life. Next week will be better.
Sweet numbers again. Thanks Sam. Maybe see a little bounce next week.
Thanks. These are ATH for total and refills.
Thanks Sam! Q2, sales force, and news all working together now.
Welcome to Q2 numbers! Thanks Sam.
I agree that Q1 effects play a role in suppressing refills, but refills should still be a multiple of new scripts. Hopefully, Amarin is running focus groups with patients and doctors to diagnose uptake issues beyond insurance. Don't get me wrong, I'm a huge believer in the science and results but if we get to where new scripts are 1M per week and refills are 1.2 M per week this will be a major problem. I understand that the numbers are not accurate, but the posted numbers indicate some issue. For all our benefit, Amarin needs to address it.
If the guy in the article bought in early 2018, he would be up way more than 200%. More like 600% growth. Nice story, but short on the math.
There is something wrong structurally with the script numbers. Refills should be a much higher multiple of new scripts. Vascepa is not like taking aspirin to make a headache go away and then your done. It should be taken for a much longer time (as long as someone wants protection against hi trigs and CVD events). We know anecdotally that Vascepa is well tolerated. So if I have a chronic CVD condition and begin taking Vascepa, I should have one new script and many refills 11X/year or 4X/year and ideally continue taking this for many years.
The Symphony-reported numbers show refills only 20% higher than new scripts. I would expect a significantly higher multiple. Something like 300% to 1000% by now.
So something doesn't add up. Are the pills too onerous to take? Are they too big to swallow? Is the data WAY off? I mean, if I had a heart attack and my doctor said I likely wouldn't get another one if i took these pills, I'd take them for the rest of my life. So, what gives?
Thanks Sam. Very nice week for a Q1. We're gonna have a lot more of these ATH weeks this year.
Thanks Sam. These are great numbers for Q1. Only 3 weeks until we start reporting on April, etc. Super news from AMRN this week. Now doctors need to go home and start saving even more patient lives.
Great numbers. Always a little pullback after a holiday rebound week. 40K is the new floor for scripts! Onward and upward. Thanks SAM
CAN YOU SAY HOCKEY STICK? Thanks for the numbers SAM.
Awesome that we are growing the pie and the slice. Can't wait for when Q2 numbers start rolling in.
Awesome numbers. Considering short week and depressed refills, this is very strong. Come April we're going to see even faster acceleration.
Great to be part of this exciting story.
Way cool numbers. Thanks SAM. Those new reps are starting to pull through new scripts. You can see refills still underperforming due to Q1 issues.
Thanks SAM. New scripts finally feeling the effect of expanded salesforce. Refills still likely depressed from the Q1 effect.
THANKS SAM. NUMBERS CONSISTENT YOY. WE SHOULD SEE LEGIT GROWTH BY MARCH.
I'll definitely be there as well. I've broken my first and last bone. Glad everyone had a nice time.
Thanks SAM.
thanks SAM. BACK TO THE MID 30s. The year starts next week
Thanks SAM. Predictable dip due to holiday week. We'll be back on track soon. Hopefully Q1 malaise will be tempered by R-IT and AHA momentum. Either way, much sunnier skies ahead. Appreciate the continued numbers.
Kick ass numbers. Beginning of AHA -driven growth? Across the board all time highs.
Dinner in Vegas? What time and is it at Venetian?
Sweet numbers. Clearly inflated from Thanksgiving, but nice to see anyways. Thanks SAM
Awesome results. Thanks for the numbers SAM
Thanks Sam. Appreciate it